Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

NeoGenomics Introduces Comprehensive Lung Solution & Feature Hematopathology Services At ASCO

NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at the American Society of Clinical Oncology
byBenzinga Newsdesk
May 28, 2024
1 minute read
Total
0
Shares
0
0
0
0
0
0

NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at the American Society of Clinical Oncology (ASCO) conference in Chicago, May 31–June 4 (booth #31093).

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts